Biosenta Statistics
Total Valuation
Biosenta has a market cap or net worth of CAD 4.31 million. The enterprise value is 10.67 million.
| Market Cap | 4.31M | 
| Enterprise Value | 10.67M | 
Important Dates
The next estimated earnings date is Tuesday, January 27, 2026.
| Earnings Date | Jan 27, 2026 | 
| Ex-Dividend Date | n/a | 
Share Statistics
Biosenta has 34.46 million shares outstanding. The number of shares has increased by 7.64% in one year.
| Current Share Class | 34.46M | 
| Shares Outstanding | 34.46M | 
| Shares Change (YoY) | +7.64% | 
| Shares Change (QoQ) | +2.52% | 
| Owned by Insiders (%) | 25.60% | 
| Owned by Institutions (%) | 6.35% | 
| Float | 25.64M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | -21.74 | 
| PB Ratio | -0.45 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -4.13 | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | -24.12 | 
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 | 
| Quick Ratio | 0.01 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | -14.39 | 
| Interest Coverage | -1.09 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -374.05% | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | 37.03% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | n/a | 
| Asset Turnover | n/a | 
| Inventory Turnover | 0.02 | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has increased by +92.31% in the last 52 weeks. The beta is -0.31, so Biosenta's price volatility has been lower than the market average.
| Beta (5Y) | -0.31 | 
| 52-Week Price Change | +92.31% | 
| 50-Day Moving Average | 0.13 | 
| 200-Day Moving Average | 0.14 | 
| Relative Strength Index (RSI) | 55.44 | 
| Average Volume (20 Days) | 3,466 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, Biosenta had revenue of CAD -198,147 and -2.58 million in losses. Loss per share was -0.08.
| Revenue | -198,147 | 
| Gross Profit | -198,879 | 
| Operating Income | -1.35M | 
| Pretax Income | -2.58M | 
| Net Income | -2.58M | 
| EBITDA | -1.35M | 
| EBIT | -1.35M | 
| Loss Per Share | -0.08 | 
Balance Sheet
The company has 4,690 in cash and 6.37 million in debt, giving a net cash position of -6.36 million or -0.18 per share.
| Cash & Cash Equivalents | 4,690 | 
| Total Debt | 6.37M | 
| Net Cash | -6.36M | 
| Net Cash Per Share | -0.18 | 
| Equity (Book Value) | -9.51M | 
| Book Value Per Share | -0.28 | 
| Working Capital | -3.69M | 
Cash Flow
In the last 12 months, operating cash flow was -416,464 and capital expenditures -25,861, giving a free cash flow of -442,325.
| Operating Cash Flow | -416,464 | 
| Capital Expenditures | -25,861 | 
| Free Cash Flow | -442,325 | 
| FCF Per Share | -0.01 | 
Margins
| Gross Margin | n/a | 
| Operating Margin | 682.84% | 
| Pretax Margin | 1,302.80% | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
Biosenta does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -7.64% | 
| Shareholder Yield | n/a | 
| Earnings Yield | -59.94% | 
| FCF Yield | -10.27% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.
| Last Split Date | Jun 28, 2016 | 
| Split Type | Reverse | 
| Split Ratio | 0.0666666666 | 
Scores
Biosenta has an Altman Z-Score of -361.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -361.31 | 
| Piotroski F-Score | 2 |